Rare diseases
Investigational molecules
Locations
A study of YL201 and atezolizumab for patients with advanced solid tumors
FranceStudy to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema
FranceA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
FranceA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
FranceA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
FranceA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
FranceA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
FranceA study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer
FranceA study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.
FranceA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
FranceA study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
FranceA study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
